Developing and testing the effectiveness of a novel online integrated treatment for problem gambling and tobacco smoking: a protocol for an open-label randomized controlled trial.

Cognitive behavioural therapy Integrated treatment Motivational interviewing Online Problem gambling Self-help Tobacco smoking

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
19 Nov 2020
Historique:
received: 10 05 2020
accepted: 03 11 2020
entrez: 20 11 2020
pubmed: 21 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

Gambling and tobacco smoking are highly comorbid among North American adults. However, there is a paucity of treatment options that are integrated (i.e. targeting both gambling and tobacco smoking simultaneously), accessible, and evidence based. The aim of this two-arm open-label randomized controlled trial is to examine the effectiveness of an online, self-guided integrated treatment for problem gambling and tobacco smoking. A target sample of 214 participants will be recruited and be randomized into either an 8-week integrated or gambling only control condition. Both conditions will consist of seven online modules following cognitive behavioural therapy and motivational interviewing principles. Our three primary outcomes are (1) the number of days gambled, (2) money spent on gambling activities, and (3) time spent in gambling activities. Secondary outcomes include gambling disorder symptoms, cigarette use, and nicotine dependence symptoms. Assessments will be completed at baseline, at completion (i.e. 8 weeks from baseline), and at follow-up (i.e. 24 weeks from baseline). Generalized linear mixed modelling will be used to evaluate our primary and secondary outcomes. We expect that participants receiving online integrated treatment will show larger reductions in gambling relative to those receiving a control gambling only intervention. We further hypothesize that reductions in smoking will mediate these group differences. The rates of problem gambling and tobacco smoking are high in North America; yet, the treatment options for both are limited, with no integrated treatments available. If supported, our pilot study will be a cost-effective and accessible way to improve treatments for co-occurring problem gambling and tobacco use. ClinicalTrials.gov NCT03614884 . Registered on August 3, 2019.

Sections du résumé

BACKGROUND BACKGROUND
Gambling and tobacco smoking are highly comorbid among North American adults. However, there is a paucity of treatment options that are integrated (i.e. targeting both gambling and tobacco smoking simultaneously), accessible, and evidence based.
METHODS METHODS
The aim of this two-arm open-label randomized controlled trial is to examine the effectiveness of an online, self-guided integrated treatment for problem gambling and tobacco smoking. A target sample of 214 participants will be recruited and be randomized into either an 8-week integrated or gambling only control condition. Both conditions will consist of seven online modules following cognitive behavioural therapy and motivational interviewing principles. Our three primary outcomes are (1) the number of days gambled, (2) money spent on gambling activities, and (3) time spent in gambling activities. Secondary outcomes include gambling disorder symptoms, cigarette use, and nicotine dependence symptoms. Assessments will be completed at baseline, at completion (i.e. 8 weeks from baseline), and at follow-up (i.e. 24 weeks from baseline). Generalized linear mixed modelling will be used to evaluate our primary and secondary outcomes. We expect that participants receiving online integrated treatment will show larger reductions in gambling relative to those receiving a control gambling only intervention. We further hypothesize that reductions in smoking will mediate these group differences.
DISCUSSION CONCLUSIONS
The rates of problem gambling and tobacco smoking are high in North America; yet, the treatment options for both are limited, with no integrated treatments available. If supported, our pilot study will be a cost-effective and accessible way to improve treatments for co-occurring problem gambling and tobacco use.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03614884 . Registered on August 3, 2019.

Identifiants

pubmed: 33213506
doi: 10.1186/s13063-020-04867-1
pii: 10.1186/s13063-020-04867-1
pmc: PMC7678080
doi:

Banques de données

ClinicalTrials.gov
['NCT03614884']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

937

Références

Clin Psychol Rev. 2007 Dec;27(8):944-58
pubmed: 17433853
J Consult Clin Psychol. 2001 Feb;69(1):50-7
pubmed: 11302277
Br J Addict. 1992 Apr;87(4):549-65
pubmed: 1591509
JMIR Ment Health. 2019 Jan 07;6(1):e65
pubmed: 30617046
J Gambl Stud. 2015 Sep;31(3):695-715
pubmed: 24880744
J Gambl Stud. 2015 Mar;31(1):299-313
pubmed: 24065314
J Med Internet Res. 2013 Aug 16;15(8):e171
pubmed: 23956024
Arch Gen Psychiatry. 2004 Nov;61(11):1107-15
pubmed: 15520358
Addiction. 2007 Mar;102(3):432-40
pubmed: 17298651
Psychopharmacology (Berl). 1999 Oct;146(4):447-54
pubmed: 10550495
Drug Alcohol Depend. 1998 Apr 1;50(2):157-65
pubmed: 9649967
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Nicotine Tob Res. 2012 Jul;14(7):833-9
pubmed: 22249688
Drug Alcohol Rev. 2009 Nov;28(6):676-81
pubmed: 19930023
J Consult Clin Psychol. 2006 Jun;74(3):555-67
pubmed: 16822112
J Dual Diagn. 2009 Apr 1;5(2):131-138
pubmed: 20182654
Drug Alcohol Depend. 1998 Jan 1;49(2):95-104
pubmed: 9543646
Ann Clin Psychiatry. 2005 Oct-Dec;17(4):237-41
pubmed: 16402757
J Addict Med. 2008;2(4):178-84
pubmed: 19690628
Clin Psychol Rev. 2016 Aug;48:7-31
pubmed: 27372437
Addict Behav. 2013 Aug;38(8):2409-13
pubmed: 23644751
Hum Psychopharmacol. 2006 Jun;21(4):255-63
pubmed: 16783813
Arch Gen Psychiatry. 1986 Mar;43(3):289-94
pubmed: 3954551
Psychiatry Res. 2009 Mar 31;166(1):76-84
pubmed: 19200607
J Clin Psychiatry. 2009 Mar;70(3):334-43
pubmed: 19254518
Addiction. 2002 Jun;97(6):745-53
pubmed: 12084144
Behav Res Ther. 2009 Jul;47(7):592-607
pubmed: 19446287
Aust N Z J Psychiatry. 2015 Jun;49(6):519-39
pubmed: 25735959
Clin Psychol Rev. 2013 Dec;33(8):1010-24
pubmed: 24029221
Addiction. 2006 Apr;101(4):534-47
pubmed: 16548933
Alcohol Clin Exp Res. 2016 May;40(5):1065-74
pubmed: 27059303
J Consult Clin Psychol. 2010 Dec;78(6):868-84
pubmed: 21114344
Exp Clin Psychopharmacol. 2003 Aug;11(3):202-9
pubmed: 12940499
Synapse. 2004 Nov;54(2):65-71
pubmed: 15352131
BMC Public Health. 2016 Jul 22;16:624
pubmed: 27449527
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
pubmed: 2899326
Addiction. 2000 May;95(5):777-89
pubmed: 10885052
J Gambl Stud. 2017 Sep;33(3):993-1010
pubmed: 28124288
Drug Alcohol Depend. 2011 Aug 1;117(1):74-7
pubmed: 21296507
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
J Consult Clin Psychol. 2011 Apr;79(2):247-252
pubmed: 21355639
J Med Internet Res. 2011 Mar 10;13(1):e30
pubmed: 21393123
Subst Use Misuse. 2009;44(7):905-14
pubmed: 19415570
Neuropsychopharmacology. 2004 Jan;29(1):195-207
pubmed: 14571257
Psychopharmacology (Berl). 2012 Mar;220(1):155-61
pubmed: 21904819
J Neurosci. 2004 Apr 28;24(17):4105-12
pubmed: 15115805
J Behav Addict. 2017 Jun 1;6(2):142-162
pubmed: 28662618
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008937
pubmed: 23152266
Addict Behav. 1982;7(4):363-71
pubmed: 7183189
J Consult Clin Psychol. 2009 Oct;77(5):950-960
pubmed: 19803574
Respir Care. 2015 Dec;60(12):1796-803
pubmed: 26286738
Addict Behav. 2015 Apr;43:72-82
pubmed: 25577724
Can J Psychiatry. 1996 Feb;41(1):36-45
pubmed: 8919422
Addiction. 2011 Mar;106(3):490-8
pubmed: 21210880
Nature. 1996 Jul 18;382(6588):255-7
pubmed: 8717040
Am J Addict. 2004 Oct-Dec;13(5):471-93
pubmed: 15764425
J Behav Addict. 2018 Dec 1;7(4):1091-1099
pubmed: 30427214
Psychol Assess. 2004 Mar;16(1):72-80
pubmed: 15023094
Addict Behav. 2002 May-Jun;27(3):465-9
pubmed: 12118632
Prim Care Companion J Clin Psychiatry. 2010;12(6):
pubmed: 21494337
Internet Interv. 2019 Mar 06;17:100239
pubmed: 30906694
BMC Public Health. 2013 Jan 08;13:10
pubmed: 23294668
Am J Psychiatry. 2008 Feb;165(2):179-87
pubmed: 18198270
Drug Alcohol Depend. 2006 Feb 1;81(2):197-204
pubmed: 16054779
J Med Internet Res. 2013 Aug 30;15(8):e162
pubmed: 23996958
J Stud Alcohol Drugs. 2012 Sep;73(5):829-33
pubmed: 22846247
Internet Interv. 2020 Jan 18;19:100307
pubmed: 32042600

Auteurs

Elena Bilevicius (E)

Department of Psychology, University of Manitoba, 190 Dysart Rd, Winnipeg, MB, R3T 2N2, Canada.

Alanna Single (A)

Department of Psychology, University of Manitoba, 190 Dysart Rd, Winnipeg, MB, R3T 2N2, Canada.

Chris Baumgartner (C)

Swiss Research Institute for Public Health and Addiction, University of Zurich, Konradstrasse 32, CH-8031, Zurich, Switzerland.

Van Bui (V)

Department of Psychology, University of Manitoba, 190 Dysart Rd, Winnipeg, MB, R3T 2N2, Canada.

Tyler Kempe (T)

Department of Psychology, University of Manitoba, 190 Dysart Rd, Winnipeg, MB, R3T 2N2, Canada.

Michael P Schaub (MP)

Swiss Research Institute for Public Health and Addiction, University of Zurich, Konradstrasse 32, CH-8031, Zurich, Switzerland.

Sherry H Stewart (SH)

Departments of Psychiatry and Psychology & Neuroscience, Dalhousie University, Abbie J Lane Building, 8th floor, 5909 Veteran's Memorial Lane, Halifax, NS, B3H 3A7, Canada.

James MacKillop (J)

Peter Boris Centre for Addictions Research McMaster University/St. Joseph's Healthcare Hamilton, 1280 Main St West, Hamilton, ON, L8S 4L8, Canada.

David C Hodgins (DC)

Department of Psychology, University of Calgary, 2500 University D NW, Calgary, AB, T2N 1N4, Canada.

Jeffrey D Wardell (JD)

Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada.

Roisin O'Connor (R)

Department of Psychology, Concordia University, 7141 Sherbrooke W., Montreal, Canada.

Jennifer Read (J)

Department of Psychology, University of Buffalo, 231 Park Hall, Buffalo, NY, 14260-4110, USA.

Heather Hadjistavropoulos (H)

Department of Psychology, University of Regina, 3737 Wascana Parkway, Regina, SK, S4S 0A2, Canada.

Christopher Sundstrom (C)

Department of Psychology, University of Regina, 3737 Wascana Parkway, Regina, SK, S4S 0A2, Canada.

Matthew T Keough (MT)

Department of Psychology, York University, 4700 Keele St, North York, ON, M3J 1P3, Canada. keoughmt@yorku.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH